Avidity Biosciences Pre-Tax Profit Margin 2019-2022 | RNA

Avidity Biosciences pre-tax profit margin from 2019 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Avidity Biosciences Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2022-03-31 $0.01B $-0.13B -1422.22%
2021-12-31 $0.01B $-0.12B -1180.00%
2021-09-30 $0.01B $-0.10B -950.00%
2021-06-30 $0.01B $-0.08B -770.00%
2021-03-31 $0.01B $-0.06B -688.89%
2020-12-31 $0.01B $-0.04B -628.57%
2020-06-30 $0.00B $-0.02B -600.00%
2020-03-31 $0.00B $-0.02B -900.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.769B $0.009B
Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies. Its lead product candidate consist AOC 1001, is designed to treat myotonic dystrophy type 1,and other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. Avidity Biosciences Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $163.597B 9.95
Bio-Rad Laboratories (BIO.B) United States $14.907B 32.33
QIAGEN (QGEN) Netherlands $10.865B 17.15
Biohaven Pharmaceutical Holding (BHVN) United States $10.248B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.228B 0.00
Arcus Biosciences (RCUS) United States $1.901B 48.18
Emergent Biosolutions (EBS) United States $1.599B 6.85
Myovant Sciences (MYOV) United Kingdom $1.236B 0.00
Zymeworks (ZYME) Canada $0.320B 0.00
Gelesis Holdings (GLS) United States $0.114B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Ambrx Biopharma (AMAM) United States $0.103B 0.00
SQZ Biotechnologies (SQZ) United States $0.087B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00